Welcome to the CGTA Research Group

Our name stands for “CNS Gene therapy Translation Acceleration.”

Our goal is to bring gene therapies for rare Central Nervous System diseases into clinical trials and use as quickly and efficiently as possible.  Our first project is focused on developing a gene therapy for Huntington’s disease.



June, 2017:

We have completed and submitted a grant application to the National Institute for Neurological Diseases and Stroke for continued pre-clinical studies of ways to improve delivery of DNA to the regions of the brain most affected in Huntington’s disease.  The Scientific Review of the grant application by an NINDS study section will occur this coming fall.


See our news page for more details.